The drug Jemperli (or dostarlimab) is now available for women who suffer from endometrial cancer.
- The endometrium is the inner lining of the body wall of the uterus and the part where pregnancy occurs.
- Endometrial cancer is the 4th cause of cancer in women in France.
- The drug Jemperli (or dostarlimab) is now available for women with endometrial cancer.
The drug Jemperli (or dostarlimab) is now available in early access for women with newly diagnosed or recurrent advanced endometrial cancer.
New treatment for endometrial cancer: when to prescribe Jemperli?
“This provision follows the early access authorization (AAP) decision granted on September 27 by the College of the High Authority for Health (HAS) for a period of 12 months, following the opinion of the ANSM. This is in favor of a strong presumption of effectiveness and safety of Jemperli in this indication”, precise ANSM on its website.
More specifically, Jemperli is indicated in combination with chemotherapy based on platinum salts in patients over 18 years of age suffering from endometrial cancer and candidates for systemic treatment which has an action on the entire body.
New treatment for endometrial cancer: what side effects?
“Only specialists in oncology and doctors competent in oncology can prescribe Jemperli according to these precise indications”, explains the ANSM. “They then give the patient a “patient card” which she must keep for the duration of her treatment,” adds the health agency.
This card includes important information from the medication leaflet and details the action to be taken in the event of a symptom suggestive of an adverse effect of immunological origin such as, for example, inflammatory pneumonitis, colitis, hepatitis, endocrinopathies, nephritis, skin reactions or even arthralgia.
Endometrial cancer: numbers and definition
The endometrium is the inner lining of the body wall of the uterus and the part where pregnancy occurs. “Cancer develops when one of the initially normal endometrial cells transforms and then multiplies in an anarchic manner until it forms a cluster of abnormal cells called a tumor,” precise the National Cancer Institute.
Endometrial cancer is the 4th cause of cancer in women in France: the number of new cases is estimated at 8,224 in 2018. This pathology generally affects women after menopause, the average age at diagnosis being 68 years.
Check out our digital video work,
only an account creation is required to access it.
